Table 1.
Brain distribution of AR subtypes and their associated brain disorders.
Receptor | Distribution | Distinct Functions and Associated Disorders | Ref | |
---|---|---|---|---|
α1 | α1A | High levels in olfactory system, hypothalamic nuclei, and brainstem. Moderate levels in amygdala, cerebral cortex, and cerebellum | Involved in neurotransmission of NE as well as γ-aminobutyric acid (GABA) and NMDA. May mediate effects of anti-depressants in treating depression and obsessive compulsive disorder (OCD) | [18,20,21,22,23,24] |
α1B | Thalamic nuclei, lateral nucleus of amygdala, cerebral cortex, some septal regions, brain stem regions | May play a role in behavioral activation. Associated with addiction, and neurodegenerative disorders (Multiple System Atrophy) | [18,20,21,24,25,26,27] | |
α1D | Olfactory bulb, cerebral cortex, hippocampus, reticular thalamic nuclei, and amygdala | Mediates changes in locomotor behaviors. Associated with stress. | [18,20,23,28,29] | |
α2 | α2A | Locus coeruleus, midbrain, hypothalamus, amygdala, cerebral cortex, and brain stem | Mediate functions of most of the α2-agonists used in sedation, antinociception, and behavioral actions. Associated with ADHD, anxiety | [18,23,30,31,32,33,34,35] |
α2B | Thalamus, hypothalamus, cerebellar Purkinje layer | Mediate antinociceptive action of nitrous oxide | [18,30,31] | |
α2C | Hippocampus, striatum, olfactory tubercle, medulla, and basal ganglia | Involved in the neuronal release of NE as well as dopamine and serotonin. Potential therapeutic targets in depression & schizophrenia |
[18,30,31,36,37,38,39] | |
β | β1 | Homologous distribution. Expression was found (mostly β1 and β2) in frontal cortex, striatum, thalamus, putamen, amygdala, cerebellum, cerebral cortex and hippocampus. | Essential to motor learning, emotional memory storage and regulation of neuronal regeneration. Associated with mood disorders, aging, Alzheimer’s disease, Parkinson’s disease. | [16,18,40,41,42,43,44,45,46,47,48] |
β2 | ||||
β3 |